Angion Biomedica Corp (ANGN)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.0000 +0.0200 (+2.04%) 06/01/23 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.0000 unch (unch) -
for Thu, Jun 1st, 2023
Results
download Want to compare other data? Select FieldsSymbol | ANGN | OSTX | KZR | ||
Company | Angion Biomedica Corp | Os Therapies Incorporated | Kezar Life Sciences Inc | ||
Price Information | |||||
Exchange | NASDAQ | NYSE Arca | NASDAQ | ||
Open | 1.0600 | 1.6800 | 4.70 | ||
High | 1.0600 | 1.9600 | 4.75 | ||
Low | 0.8901 | 1.6800 | 4.33 | ||
Last | 1.0000 | 1.8200 | 4.33 | ||
Change | +0.0200 | +0.2200 | -0.37 | ||
% Change | +2.04% | +13.75% | -7.87% | ||
Volume | 224,800 | 524,800 | 12,000 | ||
20-Day Average Volume | 169,795 | 195,625 | 23,495 | ||
Previous Close | 0.9800 | 1.6000 | 4.70 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | No | Yes | ||
Technicals | |||||
20-Day Moving Average | 0.8324 | 1.4605 | 4.33 | ||
20-Day Raw Stochastic | 72.09% | 83.33% | 52.59% | ||
20-Day Relative Strength | 67.80% | 55.37% | 41.26% | ||
Weighted Alpha | +0.20 | -53.22 | -60.20 | ||
Today's Opinion | 56% Buy | N/A | 96% Sell | ||
Previous Opinion | 40% Buy | N/A | 88% Sell | ||
Last Month's Opinion | 40% Sell | N/A | 100% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +21.95% since 05/24/23 | +22.15% since 04/21/25 | +4.34% since 04/21/25 | ||
Low | 0.8000 on 05/25/23 | 1.3600 on 04/24/25 | 4.28 on 04/22/25 | ||
High | 1.1200 on 05/31/23 | 1.9600 on 04/28/25 | 4.81 on 04/24/25 | ||
1-Month | |||||
%Chg | +49.25% since 05/01/23 | +12.35% since 03/28/25 | -11.99% since 03/28/25 | ||
Low | 0.6500 on 05/02/23 | 1.1200 on 04/10/25 | 3.62 on 04/04/25 | ||
High | 1.1200 on 05/31/23 | 1.9600 on 04/28/25 | 4.97 on 03/31/25 | ||
3-Month | |||||
%Chg | +66.14% since 03/01/23 | -30.00% since 01/28/25 | -33.18% since 01/28/25 | ||
Low | 0.4600 on 03/21/23 | 1.1200 on 04/10/25 | 3.62 on 04/04/25 | ||
High | 1.1200 on 05/31/23 | 3.5300 on 01/29/25 | 6.65 on 01/31/25 | ||
6-Month | |||||
%Chg | +21.95% since 12/01/22 | -37.46% since 10/28/24 | -43.95% since 10/28/24 | ||
Low | 0.4600 on 03/21/23 | 1.1200 on 04/10/25 | 3.62 on 04/04/25 | ||
High | 1.1200 on 05/31/23 | 7.0000 on 01/15/25 | 8.45 on 10/30/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 30,114 | 30,330 | 30,100 | ||
Shares Outstanding, K | 30,114 | 21,664 | 7,306 | ||
Annual Sales | 2,300,000 | 0 | 0 | ||
Annual Net Income | -38,810,000 | -8,880,000 | -83,740,000 | ||
Last Quarter Sales | 0 | 0 | 0 | ||
Last Quarter Net Income | -4,540,000 | -2,990,000 | -20,220,000 | ||
60-Month Beta | 0.59 | N/A | 0.61 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.15 on 05/10/23 | -0.24 on 03/31/25 | -2.77 on 03/25/25 | ||
Latest Earnings Date | 05/15/23 | 04/04/25 | 05/08/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |